APA (7th ed.) Citation

Lance Wollenberg, Erik Hahn, Jason Williams, & Kevin Litwiler. (2023). A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects. Wiley.

Chicago Style (17th ed.) Citation

Lance Wollenberg, Erik Hahn, Jason Williams, and Kevin Litwiler. A Phase I, Single‐center, Open‐label Study to Investigate the Absorption, Distribution, Metabolism and Excretion of Encorafenib Following a Single Oral Dose of 100 mg [14C] Encorafenib in Healthy Male Subjects. Wiley, 2023.

MLA (9th ed.) Citation

Lance Wollenberg, et al. A Phase I, Single‐center, Open‐label Study to Investigate the Absorption, Distribution, Metabolism and Excretion of Encorafenib Following a Single Oral Dose of 100 mg [14C] Encorafenib in Healthy Male Subjects. Wiley, 2023.